120 related articles for article (PubMed ID: 31771905)
41. Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.
Cen D; Chen J; Li Z; Zhao J; Cai X
PLoS One; 2017; 12(11):e0187588. PubMed ID: 29136022
[TBL] [Abstract][Full Text] [Related]
42. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
Chida S; Okayama H; Noda M; Saito K; Nakajima T; Aoto K; Hayase S; Momma T; Ohki S; Kono K; Takenoshita S
Carcinogenesis; 2016 Sep; 37(9):878-887. PubMed ID: 27287872
[TBL] [Abstract][Full Text] [Related]
43. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
Kim D; Viswanathan K; Goyal A; Rao R
Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
[TBL] [Abstract][Full Text] [Related]
44. Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1?
Qiu W; Christakis I; Stewart AA; Vodopivec DM; Silva-Figueroa A; Chen H; Woodard TL; Halperin DM; Lee JE; Yao JC; Perrier ND
Clin Endocrinol (Oxf); 2017 Jun; 86(6):791-797. PubMed ID: 28273369
[TBL] [Abstract][Full Text] [Related]
45. Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours.
Zandee WT; van Adrichem RC; Kamp K; Feelders RA; van Velthuysen MF; de Herder WW
Clin Endocrinol (Oxf); 2017 Aug; 87(2):165-170. PubMed ID: 28464233
[TBL] [Abstract][Full Text] [Related]
46. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.
Birnbaum DJ; Gaujoux S; Cherif R; Dokmak S; Fuks D; Couvelard A; Vullierme MP; Ronot M; Ruszniewski P; Belghiti J; Sauvanet A
Surgery; 2014 Jan; 155(1):13-21. PubMed ID: 24238123
[TBL] [Abstract][Full Text] [Related]
47. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy.
Arvold ND; Willett CG; Fernandez-del Castillo C; Ryan DP; Ferrone CR; Clark JW; Blaszkowsky LS; Deshpande V; Niemierko A; Allen JN; Kwak EL; Wadlow RC; Zhu AX; Warshaw AL; Hong TS
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e337-43. PubMed ID: 22414286
[TBL] [Abstract][Full Text] [Related]
48. Stromal Versican Regulates Tumor Growth by Promoting Angiogenesis.
Asano K; Nelson CM; Nandadasa S; Aramaki-Hattori N; Lindner DJ; Alban T; Inagaki J; Ohtsuki T; Oohashi T; Apte SS; Hirohata S
Sci Rep; 2017 Dec; 7(1):17225. PubMed ID: 29222454
[TBL] [Abstract][Full Text] [Related]
49. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
[TBL] [Abstract][Full Text] [Related]
50. Differentiation between pancreatic metastases from clear cell renal cell carcinoma and pancreatic neuroendocrine tumor using double-echo chemical shift imaging.
Lyu HL; Cao JX; Wang HY; Wang ZB; Hu MG; Ma L; Wang YW; Ye HY
Abdom Radiol (NY); 2018 Oct; 43(10):2712-2720. PubMed ID: 29500651
[TBL] [Abstract][Full Text] [Related]
51. Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.
Snyder JM; Washington IM; Birkland T; Chang MY; Frevert CW
J Histochem Cytochem; 2015 Dec; 63(12):952-67. PubMed ID: 26385570
[TBL] [Abstract][Full Text] [Related]
52. Biotherapy of pancreatic neuroendocrine tumors using somatostatin analogs.
Igarashi H; Hijioka M; Lee L; Ito T
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):618-22. PubMed ID: 25689143
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
[TBL] [Abstract][Full Text] [Related]
55. Deep learning for World Health Organization grades of pancreatic neuroendocrine tumors on contrast-enhanced magnetic resonance images: a preliminary study.
Gao X; Wang X
Int J Comput Assist Radiol Surg; 2019 Nov; 14(11):1981-1991. PubMed ID: 31555998
[TBL] [Abstract][Full Text] [Related]
56. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
[TBL] [Abstract][Full Text] [Related]
57. Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group.
Heidsma CM; Hyer M; Tsilimigras DI; Rocha F; Abbott DE; Fields R; Smith PM; Poultsides GA; Cho C; Maithel SK; Pawlik TM;
J Surg Oncol; 2020 Jun; 121(8):1201-1208. PubMed ID: 32185804
[TBL] [Abstract][Full Text] [Related]
58. Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.
Shiba S; Morizane C; Hiraoka N; Sasaki M; Koga F; Sakamoto Y; Kondo S; Ueno H; Ikeda M; Yamada T; Shimada K; Kosuge T; Okusaka T
Pancreatology; 2016; 16(1):99-105. PubMed ID: 26718527
[TBL] [Abstract][Full Text] [Related]
59. Sunitinib shrinks NET-G3 pancreatic neuroendocrine neoplasms.
Mizuno Y; Kudo A; Akashi T; Akahoshi K; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tanaka S; Tateishi U; Tanabe M
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1155-1163. PubMed ID: 29602973
[TBL] [Abstract][Full Text] [Related]
60. [Radiofrequency ablation of pancreatic neuroendocrine tumor].
Hlavsa J; Procházka V; Kala Z; Man M; Andrasina T; Cíhalová M; Válek V; Crha M; Svobodová I; Urbanová L
Klin Onkol; 2011; 24(3):209-15. PubMed ID: 21717790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
